METTL14 and hepatocellular carcinoma: This LPS–METTL14–MIR155HG–PD-L1 axis was validated in HepG2 xenografts and was particularly prominent in HCC with cirrhosis, suggesting a novel m6A-dependent lncRNA regulatory pathway contributing to HCC immune escape (43).